Advising IW Capital Ltd as the lead investor in a £10.35m investment round into Strolll Limited.

Strolll is a pioneering digital therapeutic software company that uses augmented reality (AR) glasses to provide clinically proven and patented neurorehabilitation to patients living with neurological disorders such as multiple sclerosis and Parkinson’s disease. Strolll enables patients to undergo therapy both within in-clinic and at-home settings, ensuring that patients can receive an increased dose of rehabilitation as compared to current standard care practices.

Strolll will use the investment to accelerate its sales and marketing activities, extend its product leadership and to expand the regulatory label, which will allow Strolll to target additional neuro-related disorders adjacent to the ones it already addresses.

Isobel Egemole, Investment Director at IW Capital, said:

We are pleased with the excellent legal support provided by Ross Hayward, Christina Anastasiou and the wider EMW team during our investment in Strolll. The EMW team delivered clear and effective legal work, ensuring we were well-informed throughout the process. Their professionalism and commerciality were key to the successful completion of our investment.

EMW has advised IW Capital Ltd since 08 November 2013.

The EMW team was led by Ross Hayward. He was assisted by Simon Arkell and Christina Anastasiou.